Trifluoroacetic acid → HCID 58173380, Verbindung

HRID 2047191Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2047191
C[Si](C)(C)CCOC[N:7](COCC[Si](C)(C)C)[C:8]1[N:13]2[N:14]=[CH:15][C:16]([C:17]3[CH:18]=[N:19][C:20]4[C:25]([CH:26]=3)=[CH:24][CH:23]=[CH:22][CH:21]=4)=[C:12]2[N:11]=[C:10]([C:27]2[CH2:32][CH2:31][N:30](C(OC(C)(C)C)=O)[CH2:29][CH:28]=2)[CH:9]=1.C(O)(C(F)(F)F)=O>>[N:19]1[C:20]2[C:25](=[CH:24][CH:23]=[CH:22][CH:21]=2)[CH:26]=[C:17]([C:16]2[CH:15]=[N:14][N:13]3[C:8]([NH2:7])=[CH:9][C:10]([C:27]4[CH2:32][CH2:31][NH:30][CH2:29][CH:28]=4)=[N:11][C:12]=23)[CH:18]=1

Komponenten

3

Edukt 2

HCID 6422Trifluoroacetic acidHCID 67494206HCID 67494206, Verbindung

Produkt 1

HCID 58173380HCID 58173380, Verbindung

Versuchsvorschrift

tert-Butyl 4-(7-(bis((2-(trimethylsilyl)ethoxy)methyl)amino)-3-(quinolin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)-5,6-dihydropyridine-1(2H)-carboxylate (0.057 mmol, 40 mg) was charged to a 20 mL scintillation vial containing 1 mL TFA. The reaction mixture was stirred at room temperature. The reaction mixture was concentrated in vacuo and purified via reverse-phase preparatory HPLC to yield 3-(quinolin-3-yl)-5-(1,2,3,6-tetrahydropyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine (m+H=343.31, retention time=2.05 min)

Aufarbeitung

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. custompurified via reverse-phase preparatory HPLC

Quellen und Nachweise

ORD-Eintrag
ord-b1c0337082954a78a4f6de1f9dcaea8a
Quelldatensatz
uspto-grants-2013_11
Patentnummer
US08591943B2

Notizen zur Reaktion

Wird geladen…